Target intelligence / Profile preview

Cytochrome P450 family 2 subfamily T member 3, pseudogene (CYP2T3P)

Target
CYP2T3P
Molecular classification
Pseudogene, Other (derived from the Enzyme superfamily, Cytochrome P450 family)
01

Overview

Cytochrome P450 family 2 subfamily T member 3, pseudogene (CYP2T3P) is a noncoding genomic sequence in humans that shares sequence similarity with functional cytochrome P450 genes. While cytochrome P450 enzymes are key in drug metabolism and synthesis of steroids, lipids, and other molecules, CYP2T3P itself is classified as a pseudogene, meaning it contains disabling mutations and does not encode a functional protein. There is no evidence that CYP2T3P is involved in any physiological processes, human disease, or drug interaction as a protein-coding gene. Like other pseudogenes, it might have regulatory functions at the transcript level, but none are established for CYP2T3P. CYP2T3P is not a drug target, receptor, enzyme, transporter, or transcription factor. The gene is present in the human genome as a pseudogene, meaning it is generally not transcribed into a functional protein and is not therapeutically relevant. The gene's nomenclature follows standard cytochrome P450 gene family conventions, but the "P" suffix denotes pseudogene status. There are no known drugs, mechanisms of action, biomarkers, or safety concerns associated with CYP2T3P. The primary aliases refer to the various conventions for cytochrome P450 gene and pseudogene naming.

Other names
Cytochrome P450, family 2, subfamily T, polypeptide 3, pseudogeneCytochrome P450, subfamily IIT, polypeptide 3 pseudogene
02

Mechanism of action

None (no protein product)

03

Biological functions

None known (as a pseudogene, it is nonfunctional in protein-coding)No evidence for known function for CYP2T3P specificallySome pseudogenes may play roles in gene regulation or as RNA transcripts (though not established for CYP2T3P)
04

Disease associations

Other (no direct role established)Pseudogenes in general may sometimes be involved in disease via regulatory mechanisms, but no disease association is currently known for CYP2T3P
05

Safety considerations

None (not a therapeutic or functional protein target)
06

Interacting drugs

None (nonfunctional pseudogene—no protein product, no drug interactions)
07

Biomarkers

None

Beyond the preview

Go deeper on Cytochrome P450 family 2 subfamily T member 3, pseudogene (CYP2T3P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome P450 family 2 subfamily T member 3, pseudogene (CYP2T3P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call